ABVC BioPharma Inc (ABVC)
1.01
-0.03
(-2.88%)
USD |
NASDAQ |
Apr 23, 09:38
ABVC BioPharma Market Cap: 10.67M for April 23, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 22, 2024 | 10.98M |
| April 19, 2024 | 10.46M |
| April 18, 2024 | 11.09M |
| April 17, 2024 | 10.77M |
| April 16, 2024 | 11.83M |
| April 15, 2024 | 11.51M |
| April 12, 2024 | 11.51M |
| April 11, 2024 | 12.14M |
| April 10, 2024 | 12.04M |
| April 09, 2024 | 12.46M |
| April 08, 2024 | 13.20M |
| April 05, 2024 | 13.41M |
| April 04, 2024 | 13.52M |
| April 03, 2024 | 13.62M |
| April 02, 2024 | 13.62M |
| April 01, 2024 | 14.47M |
| March 28, 2024 | 13.83M |
| March 27, 2024 | 12.67M |
| March 26, 2024 | 13.52M |
| March 25, 2024 | 11.09M |
| March 22, 2024 | 11.30M |
| March 21, 2024 | 11.19M |
| March 20, 2024 | 11.31M |
| March 19, 2024 | 11.83M |
| March 18, 2024 | 12.25M |
| Date | Value |
|---|---|
| March 15, 2024 | 12.36M |
| March 14, 2024 | 12.67M |
| March 13, 2024 | 12.99M |
| March 12, 2024 | 13.31M |
| March 11, 2024 | 12.88M |
| March 08, 2024 | 13.20M |
| March 07, 2024 | 10.69M |
| March 06, 2024 | 10.61M |
| March 05, 2024 | 10.35M |
| March 04, 2024 | 10.61M |
| March 01, 2024 | 10.09M |
| February 29, 2024 | 10.35M |
| February 28, 2024 | 10.39M |
| February 27, 2024 | 10.52M |
| February 26, 2024 | 10.61M |
| February 23, 2024 | 10.26M |
| February 22, 2024 | 10.35M |
| February 21, 2024 | 10.18M |
| February 20, 2024 | 10.26M |
| February 16, 2024 | 10.86M |
| February 15, 2024 | 10.95M |
| February 14, 2024 | 10.78M |
| February 13, 2024 | 11.29M |
| February 12, 2024 | 11.46M |
| February 09, 2024 | 11.29M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
3.477M
Minimum
Sep 22 2023
398.12M
Maximum
Apr 23 2019
73.06M
Average
65.37M
Median
Market Cap Benchmarks
| NeuBase Therapeutics Inc | 1.492M |
| Sutro Biopharma Inc | 293.07M |
| Reviva Pharmaceuticals Holdings Inc | 87.66M |
| Flora Growth Corp | 17.95M |
| Journey Medical Corp | 69.96M |
Market Cap Related Metrics
| PS Ratio | 30.79 |
| Price to Book Value | 1.272 |
| Price | 1.01 |
| Earnings Yield | -246.8% |